Collection Overview

Scientific Reports has launched a Guest-Edited Collection on Fibromyalgia and comorbid psychiatric disorders.

Fibromyalgia is a common chronic pain condition, affecting the quality of life of affected individuals. It is typically characterized by widespread musculoskeletal pain, but psychiatric disorders, such as depression and anxiety, often co-exist. The prevalence of fibromyalgia is particularly high among women, yet the presence of multiple symptoms and comorbidities make fibromyalgia particularly difficult to diagnose and manage.

This will be a Collection of original research papers and will be open for submissions from all authors – on the condition that the manuscripts fall within the scope of the Collection and of Scientific Reports more generally. We are welcoming submissions until 24th January 2026.

This Collection also supports and amplifies research related to: SDG 3 - Good health and well-being - Good health and well-being

Q&A with Dr. Tatsunori Ikemoto (Guest Editor):

Why do you feel this topic is relevant and important to the field or wider world?
The topic of Fibromyalgia (FM) is critically relevant as it remains a prevalent, disabling syndrome characterized by persistent, widespread pain, fatigue, and sleep disturbance, affecting a significant portion of the global population and requiring clarification across diagnostic, pathogenetic, and therapeutic aspects.

Why are you excited about this Collection?
This condition's complexity, with its not completely understood pathogenesis, makes a dedicated collection particularly exciting. Recent advancements in understanding immunological mechanisms, neuroinflammation (e.g., anti-satellite glial cell IgG antibodies and neutrophil role), and the potential of non-pharmacological interventions like non-invasive brain stimulation and exercise programs underscore the field's dynamism.

What do you think the impact of this Collection could be for the field?
The impact of this collection could be substantial, guiding the translation of new pathogenic insights and emerging treatments into clinical practice. By aggregating focused research, it will facilitate a more comprehensive understanding of FM as a dimensional disorder and provide robust evidence for diagnostic and management strategies, potentially improving the quality of life for millions.

In your view, why should a researcher submit to this Collection in particular?
A researcher should submit to this collection to ensure their work reaches the specific audience who needs it most, contributing to a concentrated effort that advances scientific knowledge and clinical utility, which is the main importance of a Collection.

Why submit to a Collection? 

Collections like this one help promote high-quality science. They are led by Guest Editors, who are experts in their fields, and In-House Editors and are supported by a dedicated team of Commissioning Editors and Managing Editors at Springer Nature. Collection manuscripts typically see higher citations, downloads, and Altmetric scores, and provide a one-stop-shop on a cutting-edge topic of interest. 

Who is involved? 

Guest Editors:

• Tatsunori Ikemoto, Aichi Medical University, Japan
• Enzo Pasquale Scilingo: University of Pisa, Italy

Internal Team:

• In-House Editor: Petroula Mousikou, Scientific Reports, Germany
• Commissioning Editor: Stuart Weir, Fully OA Brands, Springer Nature, UK
• Managing Editor: Rebecca Chan, Fully OA Brands, Springer Nature, UK

How can I submit my paper? 

Visit the Collection page  to find out more about this Collection and how to submit your article.